StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) stock

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.22−0.10 (-3.01%)

Close on Nov 17, 2026Market cap $622.22MP/E –Yield –

Inventiva r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was €87.04M, down 4.2% from the year before. The highest annual figure on record is €110.01M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025€87.04M-4.2%
FY2024Dec 31, 2024€90.88M-17.4%
FY2023Dec 31, 2023€110.01M+81.9%
FY2022Dec 31, 2022€60.47M+24.8%
FY2021Dec 31, 2021€48.45M+104.3%
FY2020Dec 31, 2020€23.72M-29.8%
FY2019Dec 31, 2019€33.79M+6.4%
FY2018Dec 31, 2018€31.76M–

More Inventiva figures

See a number that looks wrong?